|Other Names||DNA repair protein complementing XP-A cells, Xeroderma pigmentosum group A-complementing protein, XPA, XPAC|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13836b was selected from the C-term region of XPA. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Involved in DNA excision repair. Initiates repair by binding to damaged sites with various affinities, depending on the photoproduct and the transcriptional state of the region. Required for UV-induced CHEK1 phosphorylation and the recruitment of CEP164 to cyclobutane pyrimidine dimmers (CPD), sites of DNA damage after UV irradiation.|
|Tissue Location||Expressed in various cell lines and in skin fibroblasts.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene encodes a zinc finger protein involved in DNAexcision repair. The encoded protein is part of the NER (nucleotideexcision repair) complext which is responsible for repair of UVradiation-induced photoproducts and DNA adducts induced by chemicalcarcinogens. Mutations in this gene are associated with xerodermapigmentosum complementation group A. Alternatively splicedtranscript variants have been found for this gene. [provided byRefSeq].
Palli, D., et al. Mutagenesis 25(6):569-575(2010)Fan, W., et al. Mol. Cell 39(2):247-258(2010)Ho-Pun-Cheung, A., et al. Pharmacogenomics J. (2010) In press :Hsieh, Y.Y., et al. Anticancer Res. 30(6):2203-2208(2010)Jelonek, K., et al. J. Appl. Genet. 51(3):343-352(2010)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.